Drugs that contain radioactive atoms for either imaging or therapy are considered radiopharmaceuticals. Targeted radiotherapy, delivering the radiopharmaceutical via intra venous injection to localize in a specific (cancerous) tissue, provides the ability to treat unknown or inaccessible tumors. The radioactive atom must be delivered to the tumor without being lost by the molecule carrying it. This work aims to identify molecules that will 1) complex radioactive rhenium, 2) deliver the therapeutic radionuclide to the tumor, and 3) prevent the loss of the metal to non-cancerous tissue. A computational screening of several molecules and synthesis of two of those has been accomplished in this work.
